Related Experiment Video
Updated: May 3, 2026
07:51
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
7.1K
Prehypertension and the cardiometabolic syndrome: targeting several risk factors to achieve maximum benefit
Niki Katsiki1, Michael Doumas, Vasilios G Athyros
1Second Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, Hippocration Hospital, Thessaloniki, Greece.
Expert Review of Cardiovascular Therapy
|February 11, 2014
Insights
Prehypertension, a precursor to hypertension, significantly elevates the risk of developing cardiometabolic syndrome. Early identification and intervention are crucial for mitigating severe cardiovascular and metabolic complications.
Area of Science:
- Cardiovascular Medicine
- Metabolic Disorders
- Hypertension Research
Background:
- Prehypertension is increasingly recognized as a critical stage preceding established hypertension.
- The association between prehypertension and the development of cardiometabolic syndrome (CMS) warrants detailed investigation.
- Understanding the pathological and clinical consequences of prehypertension in relation to CMS is essential for preventative strategies.
Discussion:
- Prehypertension is not merely a transitional phase but carries inherent risks for cardiovascular and metabolic pathologies.
- The cardiometabolic syndrome, characterized by a cluster of risk factors, is significantly exacerbated by the presence of prehypertension.
- Clinical manifestations range from endothelial dysfunction to overt metabolic disturbances, highlighting the systemic impact.
Key Insights:
- Prehypertension is a significant independent risk factor for the development of cardiometabolic syndrome.
- Pathological changes associated with prehypertension contribute to the clustering of metabolic abnormalities.
- Clinical consequences include increased risk of type 2 diabetes, dyslipidemia, and cardiovascular events.
Outlook:
- Further research should focus on targeted interventions for prehypertension to prevent CMS.
- Long-term studies are needed to elucidate the full spectrum of consequences and optimal management strategies.
- Integrating prehypertension screening into routine cardiovascular risk assessments is recommended.
Abstract:
Response to: Duprez D, Toleuova A. Prehypertension and the cardiometabolic syndrome: pathological and clinical consequences. Expert Rev Cardiovasc Ther 2013;11(12):1725-33.
Related Concept Videos
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
1.0K
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
1.0K
01:29Hypertension II: Pathophysiology
1.8K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.8K
01:28Hypertension I: Introduction
1.2K
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.2K
01:30Coronary Artery Disease I: Introduction
1.8K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
01:26Atherosclerosis III: Management
741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
01:18Hypertension and Regulation of Blood Pressure
3.8K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.8K